FDA & Internet: Lessons & Scenarios for Biopharma Communicators

This panel, moderated by David Maizenberg, will feature former Division Director at FDA and 30 year biopharma veteran, Max Talbott, Joanna Napp, Healthcare and IP partner at Jackson Walker, and health care law expert Jeffery Drummond. The discussion will cover FDA regulation of Internet-based communications by biopharmaceutical companies, starting with the recent keyword advertising warning letters and subsequent draft regulations. The panel will also delve into possible scenarios for biopharmaceutical company participation in conversational and social media: the next frontier for communications with doctors, patients and wider communities of interest.

Presenting

Max Talbott, FDA; Joanna Napp, Jackson Walker; Jeffery Drummond, Jackson Walker

Channel

Medicine and Healthcare

Date

Jul 23 2009

Duration

00:59

Tags

Social, Media, Biopharmaceutical, FDA, Regulation